Generation of a Novel In Vitro Model to Study Endothelial Dysfunction from Atherothrombotic Specimens

ConclusionsCEO cells can be reliably isolated and cultured from thrombectomy specimens in patients with acute coronary syndrome. Compared to controls, patient-derived coronary endothelial cells had impaired capacity to proliferate, migrate, and contribute to angiogenesis. CEO cells could be used to identify novel therapeutic targets to enhance endothelial function and prevent acute coronary syndromes.
Source: Cardiovascular Drugs and Therapy - Category: Cardiology Source Type: research